Uncategorized
FDA program tracks post-LASIK patient-reported outcomes
CHICAGO — U.S. Food and Drug Administration studies have shown good post-LASIK visual outcomes and low complication rates, a speaker told colleagues here.The LASIK Quality of Life Collaboration Project involves the evaluation of patient-reported outcomes (PROs) recorded on web-based and paper questionnaires, Malvina B. Eydelman, MD, director of the FDA’s Division of Ophthalmic and Ear, Nose and Throat Devices, said during the keynote lecture at Refractive Surgery Subspecialty Day, preceding the American Academy of Ophthalmology meeting.